Hyperbaric Oxygen Treatment in Research and Clinical Practice - Mechanisms of Action in Focus 2018
DOI: 10.5772/intechopen.76569
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of HBO-Induced Vascular Functional Changes in Diabetic Animal Models

Abstract: The mechanisms by which HBO exerts its potentially beneficial effects are not completely clear. Interactions of mechanisms affecting endothelial dysfunction, NO synthesis, EETs and HETE formation, CYP expression changes, oxidative stress and antioxidant defense system changes, and multiple effects on inflammation take place that might be considered as mediating factors for the observed positive (or negative) clinical effects in diabetes mellitus (for instance in chronic diabetic wounds). Studies on vasculature… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 103 publications
(119 reference statements)
0
2
0
Order By: Relevance
“…The exact mechanisms by which HBO achieves its beneficial angiogenic action are not completely investigated. However, it was found that HBOT stimulates the release of EPCs and increases the production of angiogenic factors such as vascular endothelial growth factor (VEGF) [ 7 , 9 , 44 ]. furthermore, a genome-wide microarray analysis was conducted by Godman et al [ 45 ] on human microvascular endothelial cells subjected to HBOT.…”
Section: Discussionmentioning
confidence: 99%
“…The exact mechanisms by which HBO achieves its beneficial angiogenic action are not completely investigated. However, it was found that HBOT stimulates the release of EPCs and increases the production of angiogenic factors such as vascular endothelial growth factor (VEGF) [ 7 , 9 , 44 ]. furthermore, a genome-wide microarray analysis was conducted by Godman et al [ 45 ] on human microvascular endothelial cells subjected to HBOT.…”
Section: Discussionmentioning
confidence: 99%
“…Endothelial cells metabolize arachidonic acid (AA) via CYP450 enzymes (ω-hydroxylase and epoxygenase), via cyclooxygenases and 5-lipooxygenase, and by non-enzymatic degradation of arachidonic acid in the presence of free radicals [ 10 ]. Epoxygenases are members of cytochrome P450 family of enzymes, which in the endothelial cell produce four epoxyeicosatrienoic acid (EET) isomers, of which 14,15-EET and 11,12-EET are the major active vasodilator metabolites [ 10 , 11 , 12 , 13 , 14 , 15 ]. ω-hydroxylase, in smooth muscle cells, promotes the production of 20-hydroxy-eicosatrienoic acid (20-HETE), which is a vasoconstrictor [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%